Recalls / Active ingredient / Adalimumab
Adalimumab
1 FDA drug recall involving the active ingredient “Adalimumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-10-10 | Class II | HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufa | Samsung Bioepis Co., Ltd. |